- Hankook Tire’s 3Q results missed consensus on combined depreciation expenses of KRW43b q-q related to its US plant and facility investment growth at home. The US plant remains in the red, but it should turn around in 1Q19 on utilization hikes
- The firm’s domestic RE tire sales rebounded on an end to efforts to strengthen its distribution network and standardize retail prices, and while OE tire sales fell y-y amid fewer business days, its combined OE-RE tire sales are likely seeing stable growth at home this quarter, which might spur a rerating. The US operation lacks labor, not demand, and once it is adequately staffed, utilization ought to reach 90%. After putting off the construction of a second US plant, the company can avoid massive capex, which should boost its dividend payouts
- We cut our target price on Hankook Tire by 10.8% to KRW58,000 to reflect annual additional depreciation of KRW80b, but the stock remains a BUY given its ongoing transformation from a manufacturer into a distributor by realigning its domestic distribution network and pursuing M&A activities with such networks worldwide
- Hugel on Oct 25 released far-worse-than forecast 3Q results, which sent its shares plunging 19.2% below their previous low
- The company’s domestic toxin and filler operations nevertheless performed well in 3Q, with the former currently normalizing, and even though its shares now trade at a level that reflects a worst-case scenario for that business, we foresee its overall results improving from this quarter
- We cut our 12-month target price to KRW340,000, but the stock remains a BUY given the likelihood of it gaining long-term earnings momentum from its expected forays into China in 2020, Europe in 2021, and the US in 2022
삼성증권 박원용
실리콘웍스(108320)
실리콘웍스-실적 서프라이즈 + 주가 하락 = 매수 기회
- 3Q18 Review: 제품(OLED) 믹스 개선 본격화
- 상장 이후 가장 저평가, 주가 하락은 매수 기회
미래에셋대우 김철중
한국타이어(161390)
Hankook Tire-Demand needs to pick up to validate price hikes